These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14585862)

  • 1. Modelling of escalating outpatient antibiotic expenditures.
    Zintzaras E; Ioannidis JP
    J Antimicrob Chemother; 2003 Dec; 52(6):1001-4. PubMed ID: 14585862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
    Payerl-Pal M
    Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists.
    Ozkurt Z; Erol S; Kadanali A; Ertek M; Ozden K; Tasyaran MA
    Jpn J Infect Dis; 2005 Dec; 58(6):338-43. PubMed ID: 16377863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe.
    Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):401-7. PubMed ID: 16735414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe.
    Coenen S; Ferech M; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):413-7. PubMed ID: 16735416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe.
    Coenen S; Muller A; Adriaenssens N; Vankerckhoven V; Hendrickx E; Goossens H;
    J Antimicrob Chemother; 2009 Jul; 64(1):200-5. PubMed ID: 19383728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009).
    Adriaenssens N; Coenen S; Versporten A; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi3-12. PubMed ID: 22096064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002.
    Högberg L; Oke T; Geli P; Lundborg CS; Cars O; Ekdahl K
    J Antimicrob Chemother; 2005 Jul; 56(1):208-15. PubMed ID: 15897223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
    Rüttimann S; Keck B; Hartmeier C; Maetzel A; Bucher HC
    Clin Infect Dis; 2004 Feb; 38(3):348-56. PubMed ID: 14727204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe.
    Coenen S; Ferech M; Malhotra-Kumar S; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):418-22. PubMed ID: 16735417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009.
    Suda KJ; Hicks LA; Roberts RM; Hunkler RJ; Danziger LH
    J Antimicrob Chemother; 2013 Mar; 68(3):715-8. PubMed ID: 23148204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data--application in a Russian hospital.
    Goryachkina K; Babak S; Burbello A; Wettemark B; Bergman U
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):636-44. PubMed ID: 18186459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change.
    Schwartzberg E; Rubinovich S; Hassin D; Haspel J; Ben-Moshe A; Oren M; Shani S
    J Clin Pharm Ther; 2006 Apr; 31(2):179-85. PubMed ID: 16635053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria.
    Slama TG; Amin A; Brunton SA; File TM; Milkovich G; Rodvold KA; Sahm DF; Varon J; Weiland D;
    Am J Med; 2005 Jul; 118 Suppl 7A():1S-6S. PubMed ID: 15993671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting.
    Buising KL; Thursky KA; Robertson MB; Black JF; Street AC; Richards MJ; Brown GV
    J Antimicrob Chemother; 2008 Sep; 62(3):608-16. PubMed ID: 18550680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.